PathoGenetix has raised $7.5 million in a second closing of a Series B financing round, bringing its total raised in the round to $11.5 million.

The company said it plans to use the funds to support commercialization of its Genome Sequence Scanning technology to identify bacteria strains.

The company raised $4 million in the first closing of the Series B round in August (IS 8/2/2011).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.